Cytyc/Roche Trials Of PCR Tests With ThinPrep Samples To Start In November
This article was originally published in The Gray Sheet
Executive Summary
Cytyc and Roche Diagnostics plan to commence patient enrollment in November for a four-site clinical trial of Roche Cobas Amplicor polymerase chain reaction technology-based testing for Chlamydia trachomatis and Neisseria gonorrhea directly from Cytyc ThinPrep Pap Test collection vial samples.
You may also be interested in...
TriPath Investment By Roche Boosts Stock 36% In August, Index Jumps 11%
A $40 mil. investment in TriPath Imaging by pharmaceutical and diagnostics giant Roche was the driving force behind a 36.1% jump in TriPath's stock price in August. The issue gained 2-3/16 to close the month at 8-1/4.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.